EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access

The current role of nuclear medicine in breast cancer

Sofia C Vaz, Carla Oliveira, Ricardo Teixeira, Lenka M Pereira Arias-Bouda, Maria João Cardoso, Lioe-Fee de Geus-Oei

The British Journal of Radiology · 2023

DOI: 10.1259/bjr.20221153 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift The British Journal of Radiology, 2023. Verfasst von Sofia C Vaz und 5 weiteren Autor:innen. Beteiligte Einrichtung: Nuclear Medicine-Radiopharmacology, Champalimaud Clinical Center, Champalimaud Foundation, Lisbon, Portugal. Hauptthemen laut MEDLINE: Breast Neoplasms, Nuclear Medicine. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 94 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Breast cancer is the most common cancer in females worldwide. Nuclear medicine plays an important role in patient management, not only in initial staging, but also during follow-up. Radiopharmaceuticals to study breast cancer have been used for over 50 years, and several of these are still used in clinical practice, according to the most recent guideline recommendations. In this critical review, an overview of nuclear medicine procedures used during the last decades is presented. Current clinical indications of each of the conventional nuclear medicine and PET/CT examinations are the focus of this review, and are objectively provided. Radionuclide therapies are also referred, mainly summarising the methods to palliate metastatic bone pain. Finally, recent developments and future perspectives in the field of nuclear medicine are discussed. In this context, the promising potential of new radiopharmaceuticals not only for diagnosis, but also for therapy, and the use of quantitative imaging features as potential biomarkers, are addressed. Despite the long way nuclear medicine has gone through, it looks like it will continue to benefit clinical practice, paving the way to improve healthcare provided to patients with breast cancer.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Breast NeoplasmsNuclear MedicineFemaleHumansPositron Emission Tomography Computed TomographyRadiopharmaceuticalsRadionuclide Imaging

Substanzen

Radiopharmaceuticals

Autor:innen und Institutionen

  • Nuclear Medicine-Radiopharmacology, Champalimaud Clinical Center, Champalimaud Foundation, Lisbon, Portugal.
  • Department of Radiology, Section of Nuclear Medicine, Leiden University Medical Center, Leiden, The Netherlands.
  • Department of Nuclear Medicine, Alrijne Hospital, Leiderdorp, The Netherlands.
  • Breast Unit, Champalimaud Clinical Center, Champalimaud Foundation, Lisbon, Portugal.
  • Faculdade de Medicina, Lisbon, Portugal.
  • Biomedical Photonic Imaging Group, University of Twente, Enschede, The Netherlands.

Zitieren

APA

Vaz, S. C., Oliveira, C., Teixeira, R., Arias-Bouda, L. M. P., Cardoso, M. J., & de Geus-Oei, L. F. (2023). The current role of nuclear medicine in breast cancer. The British Journal of Radiology. https://doi.org/10.1259/bjr.20221153

Vancouver

Vaz SC, Oliveira C, Teixeira R, Arias-Bouda LMP, Cardoso MJ, de Geus-Oei LF. The current role of nuclear medicine in breast cancer. The British Journal of Radiology. 2023. doi:10.1259/bjr.20221153

BibTeX
@article{Vaz2023,
  author = {Vaz, Sofia C and Oliveira, Carla and Teixeira, Ricardo and Arias-Bouda, Lenka M Pereira and Cardoso, Maria João and de Geus-Oei, Lioe-Fee},
  title = {The current role of nuclear medicine in breast cancer},
  journal = {The British Journal of Radiology},
  year = {2023},
  doi = {10.1259/bjr.20221153}
}
Kostenlos starten →